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Introduction 
References 
 
• Fertility issues  
• Insulin resistance  
• Type 2 diabetes  
• Hyper- 
     cholesterolemia  
• Infrequent ovulation 
• Heart disease  
• Greater risk HTN 
• Sleep apnea  
• Fatty liver disease 
  
. 
 
 Otterbein University, Westerville, Ohio  
Underlying Pathophysiology 
The main goal of this 
project was to educate 
peers on the 
pathophysiology of a 
disease or disorder of 
choice. The topic to be 
discussed is Polycystic 
Ovarian Syndrome 
(PCOS). This topic was 
chosen based on personal 
interest in women’s 
health issues. 
PCOS is a metabolic 
disease affecting 5-10 
percent of women of 
childbearing age 
(Morgan, 2013). 
Characteristics of PCOS 
include enlarged ovaries 
consisting of multiple 
small cysts surrounding 
the outer ovary, with 
unknown cause (Morgan, 
2013). Leading to the 
ovaries producing an 
increased amount of 
androgen (male 
hormones) (Morgan, 
2013). 
Signs/Symptoms 
 
 
• Obesity (50%) of patients 
• Excessive facial and body hair  
• Increased muscle size 
• Reduced breast size  
• Acne  
• Amenorrhea (absent menstrual cycles) 
• Menstrual irregularities  
• Anovulation 
• Hyper androgenism 
• Insulin resistance 
• Cardio-metabolic abnormal 
• Ovarian polycystic appearance on 
ultrasound 
 
 
 
 
Exercises 2-4x/week for 
at least 30min. 
Diet is moderately healthy. 
Meds: Prenatal vitamin, Fish 
oil, Sectral 
Allergies: NKDA 
Labs: LH, Testosterone, 
Insulin/glucose. WNL= FSH, 
cholesterol/triglycerides 
(Pannill, 2002) 
U/S: consistent with PCOS 
 
 
Case Study 
 TT is a 28yo African American female with c/o 
irregular periods. Her 
LMP was 6 months prior 
and her periods have 
been irregular since 
menarche (Pannill, 2002). 
She mentioned a 35lb 
weight gain over 7 
months. She is married 
and uses no form of 
contraception but does 
not desire to get 
pregnant at this time. 
Other complaints include 
increase in acne on her 
face and back as well as 
excess hair growth on her 
face, chest and stomach, 
which is causing her to 
experience low self 
esteem. The increase in 
hair growth has lead to 
her needing to shave 
every few days (Pannill, 
2002). 
PMHx: Obesity, HTN 
FHx: HTN, Type II DM 
SHx: Wisdom teeth 
removal, bunion surgery 
both feet 
SocHx: Pt is a social 
worker. Social drinker 2-
3drinks/week. Denies 
tobacco use or 
recreational drugs. 
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Implications for Nursing Care 
• Be supportive  
• Assist patient in learning to manage sugar cravings  
• Encourage pt to continue with exercise regimen 
• Educate about anti-inflammatory diet and lifestyle 
Conclusion  
Pt has positive findings consistent with PCOS. She does not 
desire to get pregnant at this time but maintaining her on 
Metformin is the suggested preventative therapy to decrease 
the chances of the long term health issues related to PCOS, such 
as heart disease, Type II DM and possible endometrial cancer. 
Not only will Metformin assist in regulating her insulin levels 
and blood sugar but it will also stabilize her hormones and 
regulate her menstrual cycles. If the patient continues this plan 
of care, pregnancy in the future may not be as challenging when 
she is ready (Pannill, 2002). 
 
